Patents by Inventor Gail Jenkins
Gail Jenkins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230114143Abstract: A method of strengthening the skin barrier by application of a composition comprising at least one mRNA biomarker and/ or mRNA biomarker group enhancement compound in which the mRNA biomarker/mRNA biomarker group is involved in comified envelope formation.Type: ApplicationFiled: March 22, 2021Publication date: April 13, 2023Inventors: Ranjit Kaur Bhogal, Gail Jenkins, Magdalena Sawicka
-
Patent number: 10456344Abstract: Disclosed is an oral or topical composition comprising a nuclear factor erythroid-2 related factor 2 agonist and a liver X receptor agonist, wherein the amounts of each of the nuclear factor erythroid-2 related factor 2 agonist and the liver X receptor agonist produce a synergistic benefit of hair fiber growth, wherein the oral or topical composition comprises ?9, preferably ?8% w/w ?-sitosterol, wherein when the oral or topical composition comprises a catechin, the oral or topical composition comprises 0.001 to 90, preferably 0.005 to 70, most preferably 0.Type: GrantFiled: December 4, 2015Date of Patent: October 29, 2019Assignee: CONOPCO, INC.Inventors: Ranjit Kaur Bhogal, Gail Jenkins, Magdalena Sawicka, Linda Jane Wainwright
-
Patent number: 10406091Abstract: The invention relates to a skin anti-ageing composition. In particular a skin anti-ageing composition comprising myricetin or glycoside thereof, and at least one LXR alpha agonist. By skin ageing is meant the appearance or manifestation of any one or more of wrinkles or sagging, poor skin barrier such as dryness, scalp itch, or uneven skin tone such as age spots.Type: GrantFiled: November 27, 2012Date of Patent: September 10, 2019Assignee: Conopco, Inc.Inventors: Gail Jenkins, Silvina Beatriz Lotito, Jennifer Elizabeth Pople, Linda Jane Wainwright
-
Publication number: 20180344603Abstract: The invention relates to a composition, in particular to an oral anti-ageing composition for treating hair ageing. This invention is based on the observation that the combination of hesperetin, a flavanone, derivable from a natural rutinoside hesperetin 7-rutinoside (also known as hesperidin) in citrus, e.g., in Citrus aurantium L, Citrus sinensis, Zanthozylum gilletti, leaves of Agathosma serratifolia, and trans-resveratrol synergistically up-regulates NQO-1 in a gene expression assay. The combination also induces Glo1, decreases MG and MG-protein glycation, decreases insulin resistance, decreases fasting plasma glucose, induces modest weight loss, improves renal function, decreases vascular inflammation marker slCAM-1, improves arterial dilatation and decreases the risk of cardiovascular disease.Type: ApplicationFiled: November 7, 2016Publication date: December 6, 2018Applicant: CONOPCO, INC., d/b/a UNILEVERInventors: Mark Ian Fowler, Gail Jenkins, David James Messenger, Naila Rabbani, Paul John Thornalley, Mingzhan Xue
-
Publication number: 20170360673Abstract: Disclosed is an oral or topical composition comprising a nuclear factor erythroid-2 related factor 2 agonist and a liver X receptor agonist, wherein the amounts of each of the nuclear factor erythroid-2 related factor 2 agonist and the liver X receptor agonist produce a synergistic benefit of hair fibre growth, wherein the oral or topical composition comprises ?9, preferably ?8% w/w ?-sitosterol, wherein when the oral or topical composition comprises a catechin, the oral or topical composition comprises 0.001 to 90, preferably 0.005 to 70, most preferably 0.Type: ApplicationFiled: December 4, 2015Publication date: December 21, 2017Applicant: Conopco, Inc., d/b/a UNILEVERInventors: Ranjit Kaur BHOGAL, Gail JENKINS, Magdalena SAWICKA, Linda Jane WAINWRIGHT
-
Publication number: 20170049676Abstract: The inventors have observed that aqueous mustard seed extract appears to be cytotoxic to fibroblast cells. The cytotoxicity of the aqueous mustard seed extract appears to abate when the extract is heat treated at 120° C. for 15 minutes. The heat treated aqueous mustard seed extract when combined with exogenous myrosinase is not cytotoxic but can induce a modest increase in HO-1 content in cultured fibroblasts and thus would be expected to be useful in a topical composition for treating/preventing itchy skin, particularly the scalp. This invention thus relates to the provision of a topical composition for treating/preventing itchy skin, particularly the scalp.Type: ApplicationFiled: April 21, 2015Publication date: February 23, 2017Applicant: Conopco, Inc., d/b/a UNILEVERInventors: Mark John BERRY, Mark lan FOWLER, Gail JENKINS, Jennifer Elizabeth POPLE, Sally Pamela REDFERN
-
Patent number: 8987329Abstract: A composition which is adapted for oral consumption and which is in the form of a substantially homogeneous aqueous emulsion, suspension or dispersion comprising salicylic acid, or a C1 to C6 alkyl ester thereof, and docosahexaenoic acid (DHA) can exhibit an anti-inflammatory effect in skin.Type: GrantFiled: April 5, 2007Date of Patent: March 24, 2015Assignee: Conopco, Inc.Inventors: John Casey, Alexander Gordon James, Gail Jenkins, Linda Jane Wainwright
-
Publication number: 20140295010Abstract: The invention relates to a skin anti-ageing composition. In particular a skin anti-ageing composition comprising myricetin or glycoside thereof, and at least one LXR alpha agonist. By skin ageing is meant the appearance or manifestation of any one or more of wrinkles or sagging, poor skin barrier such as dryness, scalp itch, or uneven skin tone such as age spots.Type: ApplicationFiled: November 27, 2012Publication date: October 2, 2014Applicant: CONOPCO, INC. D/B/A UNILEVERInventors: Gail Jenkins, Silvina Beatriz Lotito, Jennifer Elizabeth Pople, Linda Jane Wainwright
-
Publication number: 20140080773Abstract: A composition suitable to improve skin characteristics is described along with a regimen to improve skin characteristics. The composition is not limited to format, and can be in the form of a capsule, tablet or food product. When consumed within a defined regimen, the composition with active mixture results in skin that is smoother and with a reduction in wrinkles.Type: ApplicationFiled: August 19, 2013Publication date: March 20, 2014Applicant: Conopco, Inc. d/b/a UNILEVERInventors: Gail Jenkins, John Casey, Julia Sarah Rogers
-
Patent number: 8546445Abstract: A composition which is adapted for oral consumption comprising daidzein and an anthocyanidin, wherein the weight ratio of daidzein to anthocyanidin is in the range of from 1:1 to 1:100, wherein the daidzein is in the form of a pre-prepared aqueous dispersion, and wherein the composition is free of soy protein, which can exhibit an anti-inflammatory effect in skin, the use of a composition containing daidzein and an anthocyanidin for obtaining an anti-inflammatory effect in the skin and a method of reducing skin inflammation through the oral consumption of the composition.Type: GrantFiled: December 3, 2009Date of Patent: October 1, 2013Assignee: Conopco, Inc.Inventors: John Casey, Gail Jenkins, Linda Jane Wainwright
-
Patent number: 8318710Abstract: Compositions comprising an LXR activator and retinoic acid and/or a metabolic precursor thereto are useful in reducing the effects of chronoageing and/or photoageing of the skin.Type: GrantFiled: June 3, 2010Date of Patent: November 27, 2012Assignee: Conopco, Inc.Inventors: Gail Jenkins, Andrew Easson Mayes
-
Patent number: 8158164Abstract: This invention relates to the provision of an edible composition for the treatment of cutaneous signs of ageing, in particular those associated with loss of skin elasticity, wrinkles and sagging. Thus the inventive composition provides skin benefits selected from the group consisting of enhancing collagen deposition in the skin, reducing the appearance of wrinkles and reducing sagging.Type: GrantFiled: February 18, 2010Date of Patent: April 17, 2012Assignee: Conopco, Inc.Inventors: John Casey, Gail Jenkins, Linda Jane Wainwright
-
Publication number: 20120083524Abstract: Composition for oral consumption in the form of a substantially 5 homogeneous aqueous emulsion, suspension or dispersion comprising genistein and docosahexaenoic acid (DHA) and less than 1% by weight of soy protein, wherein the weight ratio of genistein to DHA is in the range of from 1:100 to 1:1, the composition comprises genistein in an amount of from 0.0001% to 0.1% by 10 weight and the genistein and DHA exhibit an anti-ageing effect on skin.Type: ApplicationFiled: September 19, 2011Publication date: April 5, 2012Applicant: CONOPCO INC., D/B/A UNILEVERInventors: John CASEY, Gail JENKINS, Linda Jane WAINWRIGHT
-
Publication number: 20110237660Abstract: A composition which is adapted for oral consumption comprising daidzein and an anthocyanidin, wherein the weight ratio of daidzein to anthocyanidin is in the range of from 1:1 to 1:100, wherein the daidzein is in the form of a pre-prepared aqueous dispersion, and wherein the composition is free of soy protein, which can exhibit an anti-inflammatory effect in skin, the use of a composition containing daidzein and an anthocyanidin for obtaining an anti-inflammatory effect in the skin and a method of reducing skin inflammation through the oral consumption of the composition.Type: ApplicationFiled: December 3, 2009Publication date: September 29, 2011Inventors: John Casey, Gail Jenkins, Linda Wainwright
-
Publication number: 20100240628Abstract: Compositions comprising an LXR activator and retinoic acid and/or a metabolic precursor thereto are useful in reducing the effects of chronoageing and/or photoageing of the skin.Type: ApplicationFiled: June 3, 2010Publication date: September 23, 2010Applicant: CONOPCO, INC., D/B/A UNILEVERInventors: GAIL JENKINS, ANDREW EASSON MAYES
-
Publication number: 20100215762Abstract: This invention relates to the provision of an edible composition for the treatment of cutaneous signs of ageing, in particular those associated with loss of skin elasticity, wrinkles and sagging. Thus the inventive composition provides skin benefits selected from the group consisting of enhancing collagen deposition in the skin, reducing the appearance of wrinkles and reducing sagging.Type: ApplicationFiled: February 18, 2010Publication date: August 26, 2010Applicant: CONOPCO, INC., D/B/A UNILEVERInventors: John Casey, Gail Jenkins, Linda Jane Wainwright
-
Publication number: 20100190847Abstract: A composition which is adapted for oral consumption and which comprises: (i) a PPAR ligand; such as EPA or DHA (ii) an oestrogen receptor binding agent; such as soy isoflavones (iii) an agent that is involved in the post-translational modification of collagen; such as ascorbic acid and (iv) a carotenoid, wherein the composition is substantially free from added zinc and/or selenium, can provide an anti-ageing effect on skin and may be used to increase collagen synthesis in skin.Type: ApplicationFiled: April 1, 2010Publication date: July 29, 2010Applicant: CONOPCO INC., D/B/A UNILEVERInventors: John CASEY, Gail JENKINS, Julia Sarah ROGERS
-
Publication number: 20100093844Abstract: A stable consumable emulsion, comprising at least 50% water, 0.2 to 3 wt % of an oil comprising at least 12 wt % of docosahexaenoic acid and eicosapentaenoic acid, an antioxidant, a flavouring and at least 0.01 wt % food-grade phospholipid emulsifier is provided which provides noticeable improvements in skin when consumed regularly.Type: ApplicationFiled: December 17, 2009Publication date: April 15, 2010Applicant: CONOPCO INC., D/B/A UNILEVERInventors: John CASEY, Gail JENKINS, Julia Sarah ROGERS, Simon David WANTLING
-
Publication number: 20090286872Abstract: Composition for oral consumption in the form of a substantially 5 homogeneous aqueous emulsion, suspension or dispersion comprising genistein and docosahexaenoic acid (DHA) and less than 1% by weight of soy protein, wherein the weight ratio of genistein to DHA is in the range of from 1:100 to 1:1, the composition comprises genistein in an amount of from 0.0001% to 0.1% by 10 weight and the genistein and DHA exhibit an anti-ageing effect on skin.Type: ApplicationFiled: April 10, 2007Publication date: November 19, 2009Inventors: John Casey, Gail Jenkins, Linda Jane Wainwright
-
Publication number: 20090239945Abstract: A composition which is adapted for oral consumption and which comprises: (i) a PPAR ligand; such as EPA or DHA (ii) an oestrogen receptor binding agent; such as soy isoflavones (iii) an agent that is involved in the post-translational modification of collagen; such as ascorbic acid and (iv) a carotenoid, wherein the composition is substantially free from added zinc and/or selenium, can provide an anti-ageing effect on skin and may be used to increase collagen synthesis in skin.Type: ApplicationFiled: March 27, 2007Publication date: September 24, 2009Inventors: John Casey, Gail Jenkins, Julia Sarah Rogers